DOI:
10.1055/s-00000017
Experimental and Clinical Endocrinology & Diabetes
LinksClose Window
References
Brantley DM, Cheng N, Thompson EJ, Lin Q, Brekken RA, Thorpe PE, Muraoka RS, Cerretti DP, Pozzi A, Jackson D, Lin C, Chen J.
Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo.
Oncogene 2002; 21: 7011-7026
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.